Compare VNRX & GDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNRX | GDC |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 4.7M |
| IPO Year | 2012 | N/A |
| Metric | VNRX | GDC |
|---|---|---|
| Price | $0.16 | $1.13 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $12.03 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 118.4K |
| Earning Date | 11-12-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,727,384.00 | N/A |
| Revenue This Year | $108.41 | N/A |
| Revenue Next Year | $208.50 | N/A |
| P/E Ratio | ★ N/A | $7.47 |
| Revenue Growth | ★ 40.04 | N/A |
| 52 Week Low | $0.13 | $0.90 |
| 52 Week High | $3.26 | $2,974.65 |
| Indicator | VNRX | GDC |
|---|---|---|
| Relative Strength Index (RSI) | 37.62 | 44.04 |
| Support Level | $0.15 | $1.05 |
| Resistance Level | $0.18 | $1.42 |
| Average True Range (ATR) | 0.02 | 0.14 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 2.89 | 53.49 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
GD Culture Group Ltd operates and manages its business as a single segment and has one operating and reportable segment, the Virtual Content Production. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.